AzTrials
AzTrials

Knee OsteoarthritisGONEARSNCT04465331

Adaptation and Validation of the Exercise Adherence Rating Scale of Knee Osteoarthritis Patients (GONEARS)

An observational study of Knee Osteoarthritis, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The origin of knee osteoarthritis is multifactorial but the disease is strongly related to age. The pain and functional disability are the main reasons for consultation. Non-pharmaceutical treatment is always indicated. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Questionnaires
How many people
100 participants
Where
1 siteFrance
Study dates
30 Dec 2019to 10 Feb 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Painful Knee Osteoarthritis with presence of osteophytes on radiography

Who may be able to join

  • Both sexes
  • Painful Knee Osteoarthritis with presence of osteophytes on radiography
  • At least 1 of the following 3 criteria's: adult >50 years old, morning stiffness <30 minutes, or in the pre-stage surgical (programmed knee prosthesis replacement).
  • Acceptance to participate in the study
  • Patients affiliated to a social security scheme (beneficiary entitled)

Who cannot join

  • Patient under guardianship, or protection of justice.
  • Cognitive impairment
  • Contraindications to Physical Activities
  • Patient in the incapacity to answer the questionnaire

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000

Other trials in France

About this study

Official title: Adaptation and Validation of the Exercise Adherence Rating Scale of Knee Osteoarthritis Patients

The origin of knee osteoarthritis is multifactorial but the disease is strongly related to age. The pain and functional disability are the main reasons for consultation. Non-pharmaceutical treatment is always indicated.

The rehabilitation will reduce the pain, maintain or partially recover the amplitude of the movements as well as fight against vicious analgesic attitudes and strengthen the muscles to stabilize the joints. A program of self-rehabilitation exercises performed at home may be prescribed to people with knee osteoarthritis. It must include exercises adapted to the patient's functional abilities and painful level and requires education to improve the patient's motivation to practice a regular exercise program. However, adherence to such exercises is low, and until 2016 there was no objective way to find out the reasons for patients' lack of adherence to self-workout programs. The EARS ("Exercise Adherence Rating Scale" or Adhesion to Physical Exercise Programs) is validated in 2016 and reliable to evaluate the physical activity of patients with low back pain.

As far as we know, this questionnaire is the only one validated in the international literature, a validation for French patients is currently underway. We believe this tool can be used for patients with knee osteoarthritis after minor changes.

Read the detailed description

EARS ("Exercise Adherence Rating Scale" or Adhesion to Physical Exercise Programs) assesses in the first part what type of physical exercise was recommended for patients with common chronic pain, as well as their frequencies and the date until which they were prescribed. The patient can also inform how often he can do his exercises, or otherwise, if he has completely stopped them, to mention since when and why.

A second part of the questionnaire explores the behavior of patients towards adherence to exercise programs and a final part examines the reasons for or not performing these exercises.

Inclusion and the first questionnaires period at the beginning of the knee rehabilitation program (program for 6 weeks). Clinical and demographic data questionnaire that will be completed by the investigating physician. The second questionnaire will be done at 48 hours from the inclusion (only the EARS questionnaire will be filled at 2 days). The third time the patients will complete the questionnaires at the end of the rehabilitation program and the last time at 4 months end half.

Being tested
Questionnaires
Keywords
Knee Osteoarthritis, Physical activity, Questionnaire, Adhesion
Medical subject headings
Osteoarthritis, Knee, Motor Activity, Tissue Adhesions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnairesOther

    completion of Exercise Adherence Rating Scale (EARS)

Study groups in NCT04465331
Study groupRoleWhat they receive
patients with knee arthrosisPainful Knee Osteoarthritis with presence of osteophytes on radiography
Receives: Other: Questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of adherence to physical exercise programs

    measured by Exercise Adherence Rating Scale (EARS)

    Measured: Day 0

  2. Assessment of adherence to physical exercise programs measured by Exercise Adherence Rating Scale (EARS)

    measured by Exercise Adherence Rating Scale (EARS)

    Measured: Day 2

  3. Assessment of adherence to physical exercise programs measured by Exercise Adherence Rating Scale (EARS)

    measured by Exercise Adherence Rating Scale (EARS)

    Measured: Day 45

  4. Assessment of adherence to physical exercise programs measured by Exercise Adherence Rating Scale (EARS)

    measured by Exercise Adherence Rating Scale (EARS)

    Measured: Day 135

Secondary outcomes (12)
  1. knowledge of emotional state measured by questionnaire HAD (Hospital Anxiety and Depression Scale )

    The Hospital Anxiety and Depression Scale (HADS) is a valid and reliable self-rating scale that measures anxiety and depression in both hospital and community settings. HADS gives clinically meaningful results as a psychological screening tool and can assess the symptom severity and caseness of anxiety disorders and depression in patients with illness and the general population.

    One questionnaire, comprising fourteen questions. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.

    Scoring : 0-7- normal, 8-10-borderling abnormal, 11-21-abnormal

    Measured: Day 0

  2. knowledge of emotional state measured by questionnaire HAD (Hospital Anxiety and Depression Scale )

    The Hospital Anxiety and Depression Scale (HADS) is a valid and reliable self-rating scale that measures anxiety and depression in both hospital and community settings. HADS gives clinically meaningful results as a psychological screening tool and can assess the symptom severity and caseness of anxiety disorders and depression in patients with illness and the general population.

    One questionnaire, comprising fourteen questions. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.

    Scoring : 0-7- normal, 8-10-borderling abnormal, 11-21-abnormal

    Measured: Day 45

  3. knowledge of emotional state measured by questionnaire HAD (Hospital Anxiety and Depression Scale )

    The Hospital Anxiety and Depression Scale (HADS) is a valid and reliable self-rating scale that measures anxiety and depression in both hospital and community settings. HADS gives clinically meaningful results as a psychological screening tool and can assess the symptom severity and caseness of anxiety disorders and depression in patients with illness and the general population.

    One questionnaire, comprising fourteen questions. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.

    Scoring : 0-7- normal, 8-10-borderling abnormal, 11-21-abnormal

    Measured: Day 135

  4. personal efficacy by means of the questionnaire ASES "Arthritis Self-Efficacy Scale"

    The ASES includes 20 questions that represent three subscales: pain, function, and other symptoms. Score ranging : from 1 to 10 (higher = greater self-efficacy).

    Measured: Day 0

  5. personal efficacy by means of the questionnaire ASES "Arthritis Self-Efficacy Scale"

    The ASES includes 20 questions that represent three subscales: pain, function, and other symptoms. Score ranging : from 1 to 10 (higher = greater self-efficacy).

    Measured: Day 45

  6. personal efficacy by means of the questionnaire ASES "Arthritis Self-Efficacy Scale"

    The ASES includes 20 questions that represent three subscales: pain, function, and other symptoms. Score ranging : from 1 to 10 (higher = greater self-efficacy).

    Measured: Day 135

  7. Patient Global Impression of Change by Scale (PGIC)

    This scale evaluates all aspects of patients' health and assesses if there has been an improvement or decline in clinical status. It consists of one item.

    Patient choose: 1 -No change (or condition has gotten worse), 2 - Almost the same, hardly any change at all, 3 - A little better, but no noticeable change, 4 - Somewhat better, but the change has not made any real difference, 5 - Moderately better, and a slight but noticeable change, 6 - Better and a definite improvement that has made a real and worthwhile difference, 7 - A great deal better and a considerable improvement that has made all the difference.

    Measured: Day 45

  8. Patient Global Impression of Change by Scale (PGIC)

    This scale evaluates all aspects of patients' health and assesses if there has been an improvement or decline in clinical status. It consists of one item.

    Patient choose: 1 -No change (or condition has gotten worse), 2 - Almost the same, hardly any change at all, 3 - A little better, but no noticeable change, 4 - Somewhat better, but the change has not made any real difference, 5 - Moderately better, and a slight but noticeable change, 6 - Better and a definite improvement that has made a real and worthwhile difference, 7 - A great deal better and a considerable improvement that has made all the difference.

    Measured: Day 135

  9. Knee injury and Osteoarthritis Outcome Score (KOOS)

    This scale evaluates all aspects the patients' opinion (symptoms, functional disability in activities of daily life or sports activities, quality of life) about their knee and hip problems, both for traumatic and degenerative joint diseases

    Measured: Day 45

  10. Knee injury and Osteoarthritis Outcome Score (KOOS)

    This scale evaluates all aspects the patients' opinion (symptoms, functional disability in activities of daily life or sports activities, quality of life) about their knee and hip problems, both for traumatic and degenerative joint diseases

    Measured: Day 135

  11. The perceived barriers to and facilitators of physical activity

    1. The perceived barriers to and facilitators of physical activity are measured by EPAP

    Measured: Day 45

  12. The perceived barriers to and facilitators of physical activity

    1. The perceived barriers to and facilitators of physical activity are measured by EPAP

    Measured: Day 135

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2020
  2. Study start30 Dec 2019
  3. Primary completion30 Oct 2021
  4. Study completion10 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04465331
Sponsor's protocol ID
RNI 2019 COUDEYRE 2
Other IDs
2019-A01680-57
Acronym
GONEARS
Status last verified
Feb 2022
First submitted
7 Jul 2020
Last updated
14 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Knee Osteoarthritis, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of adherence to physical exercise programs (time frame: Day 0). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in